STAAR Surgical Q3 2023 earnings call transcript furnished; exhibit incomplete

STAAR SURGICAL CO

2023-Q3 EPS reported $0.27 revenue$246,142,000

Filing includes transcript of November 1, 2023 conference call for quarter ended September 29, 2023.
Transcript provided is partial (introductory remarks only); financial results not included in this 8-K.
No specific EPS, revenue, or guidance figures available from the furnished exhibit.
Press release of Q3 results was issued separately before the call; this filing is procedural.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.